Acadia Pharmaceuticals Inc. (ACAD)

[Tanis2476]

I'm watching this and if it dips below $22 I'm in. The company made an error when they priced the product so high into the specialty range and distribution is hampered by only being available through Specialty Pharmacies. They should have launched with a cost of $700 and made gradual price increases every 6 months and when the next indications come along. This is a good example of a company being too greedy at approval and outsmarting themselves. The need for the product is def there, but few will pay for it at this price.